DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$24,955,000
-9.4%
145,000
-33.9%
0.49%
-0.4%
Q2 2021$27,545,000
-7.5%
219,5000.0%0.49%
-21.9%
Q1 2021$29,766,000
-44.8%
219,500
-47.9%
0.63%
-41.3%
Q4 2020$53,942,000
+13.7%
421,6190.0%1.07%
-7.7%
Q3 2020$47,445,000
+18.1%
421,6190.0%1.16%
-1.3%
Q2 2020$40,168,000
+30.3%
421,619
+22.9%
1.17%
+19.6%
Q1 2020$30,825,000
-57.6%
343,000
-75.0%
0.98%
-57.8%
Q4 2019$72,618,000
+40.8%
1,369,625
+4.9%
2.32%
+10.2%
Q3 2019$51,567,000
-3.8%
1,305,1740.0%2.10%
+9.1%
Q2 2019$53,617,000
-8.3%
1,305,174
+4.0%
1.93%
-14.1%
Q1 2019$58,453,000
-3.2%
1,255,174
-9.5%
2.24%
-7.3%
Q4 2018$60,384,000
-5.6%
1,386,541
+24.1%
2.42%
+5.5%
Q3 2018$63,963,000
+17.0%
1,117,651
-0.8%
2.29%
+19.3%
Q2 2018$54,672,000
+127.4%
1,126,800
+83.2%
1.92%
+130.5%
Q1 2018$24,047,000
-7.9%
615,0000.0%0.83%
-18.9%
Q4 2017$26,101,000
+13.7%
615,0000.0%1.03%
-0.7%
Q3 2017$22,952,000
+146.0%
615,000
+74.0%
1.03%
+160.5%
Q1 2016$9,329,000
-10.4%
353,491
+65.6%
0.40%
-5.9%
Q4 2015$10,410,000213,4910.42%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders